News | May 07, 2023
Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The collaboration between CORONA and Ferring will cater to patients across India
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Subscribe To Our Newsletter & Stay Updated
